期刊文献+

组织因子和基质金属蛋白酶-9在乳腺癌中的表达与预后分析 被引量:6

The Expression of Transferrin and MMP-9 in Breast Cancer and Its Significance in Prognosis
下载PDF
导出
摘要 目的:研究乳腺癌组织中组织因子(tissuefactor,TF)和基质金属蛋白酶-9(matrixmetalloproteinase-9,MMP-9)的表达并分析其阳性表达与预后的关系。方法:应用二步法(EnVision)免疫组化方法检测71例乳腺癌组织中TF和MMP-9的表达情况并分析其随访资料。结果:TF和MMP-9在71例乳腺癌组织中染色阳性率分别为43.7%和42.3%。K-M法单因素分析显示其阳性表达患者的5年生存率低于阴性患者(P<0.05)。COX多因素分析提示TNM分期、淋巴结转移是乳腺癌的预后因子,而TF、MMP-9不能作为独立预后因子(P>0.05)。结论:TF和MMP-9在乳腺癌组织中的阳性表达率较高,对判断患者的预后有一定的作用。 Objective: To detect the expression of transferrin (TF) and MMP-9 in breast cancer and to investigate its significance in prognosis. Methods: The expression of TF and MMP-9 in 71 breast cancer specimens was detected by EnVision immunohistochemistry. Results: The positive expression rate of TF and MMP-9 was 43.7% and 42.3%, respectively. Kaplan-Meier survival curves showed that the 5-year survival rate of the patients with positive expression of TF and MMP-9 was lower than that of the patients with negative expression of TF and MMP-9(P〈0.05). However, multivariate analysis showed that TNM-staging and lymph node metastasis were significant prognostic factors, and the expression of TF and MMP-9 were not independent prognostic factors (P〉0.05). Conclusion: The positive rate of TF and MMP-9 expression was high in breast cancer tissues. TF and MMP-9 expression levels might be able to provide prognostie infformation.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2008年第1期22-25,共4页 Chinese Journal of Clinical Oncology
基金 国家自然科学基金资助(编号:30471683)
关键词 乳腺癌 基质金属蛋白酶 组织因子 免疫组织化学 预后 Breast cancer MMP-9, TF Immunohistochemistry Prognosis
  • 相关文献

参考文献11

  • 1Contrino J,Hair G,Kreutzer DL,et al.In situ detection of tissue factor in vascular endothelial cells:correlation with the malignant phenotype of human breast disease[J].Nat Med,1996,2(2):209-215
  • 2Bartsch JE,Staren ED,Appert HE.Matrix metalloproteinase expression in breast cancer[J].J Surg Res,2003,110(2):383 -392
  • 3Sorensen BB,Rao LV,Tornehave D,et al.Antiapoptotic effect of coagulation factor Ⅶa[J].Blood,2003,102(5):1708-1715
  • 4Rickles FR,Shoji M,Abe K.The role of the hemostatic system in rumor growth,metastasis,and angiogenesis:tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer[J].Int J Hematol,2001,73(2):145-150
  • 5Koblinski JE,Ahram M,Sloane BF.Unraveling the role of proteases in cancer[J].Clin Chim Acta,2000,291(2):113-135
  • 6La Rocca G,Pucci-Minafra I,Marrazzo A,et al.Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera[J].Br J Cancer,2004,90(7):1414-1421
  • 7张祖平,郭爱萍,王玉龙,梁建芳.MMP-9在乳腺癌中的表达及临床意义[J].中国肿瘤临床,2002,29(1):72-73. 被引量:10
  • 8万远廉,戎龙,刘玉村,汪欣,吴涛,潘义生,姚宏伟,叶京明,汤坚强,朱静.组织因子对大肠癌侵袭能力的影响及其与基质金属蛋白酶-9的关系[J].中华实验外科杂志,2004,21(9):1087-1088. 被引量:17
  • 9Ueno T,Toi M,Koike M,et al.Tissue factor expression in breast cancer tissues:its correlation with prognosis and plasma concentration[J].Br J Cancer,2000,83 (2):164-170
  • 10Ranuncolo SM,Armanasco E,Cresta C,et al.Plasma MMP-9(92 kDa-MMP) activity is useful in the follow-up and in the assessment of prognosis in breast cancer patients[J].Int J Cancer,2003,106(5):745-751

二级参考文献24

  • 1Natalie SC,Nissi V,Vijaya MR.Immunohistochemical identification of tissue factor in solid tumors.Cancer,1992,70:1194-1201.
  • 2Abdulkadir SA,Carvalhal GF,Kaleem Z,et al.Tissue factor expression and angiogenesis in human prostate carcinoma.Hum Pathol,2000,31:443-447.
  • 3Rickles FR,Falanga A.Molecular basis for the relationship between thrombosis and cancer.Thromb Res,2001,102:215-224.
  • 4Kleiner DE,Stetler-Stevenson WG.Matrix metalloproteinases and metastasis.Cancer Chemother Pharmacol,1999,43:s42-51.
  • 5Siddiqui FA,Siddiqui TF,Francis JL.Hemoglobin induces the production and release of matrix metalloproteinase-9 from human malignant cells.Blood Coagul Fibinolysis,2003,14:449-455.
  • 6Herman MP,Sukhova GK,Kisiel W,et al.Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis.J Clin Invest,2001,107:1117-1126.
  • 7Ott I,Fischer EG,Miyagi Y,et al.A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280.J Biol,1998,140:1241-1253.
  • 8Yoshikawa T, Tsuburaya A, Kobayashi O, et al. Intratumoral concentrations of tissue inhibitor of matrix metalloproteinase 1 in patients with gastric carcinoma[J]. Cancer, 2001, 91 (8):1739 - 1747.
  • 9Kleiner DE, Stealer-stevenson WG. Matrix metalloproteinases and metastasis[J]. Cancer Chemother Pharmacol, 1999, 43:42-51.
  • 10Steder-stevenson WG. Matrix metallo proteinase inhibitors, in cancer therapeutics:experimental and clinical agents (ed: Teicher,B)[M]. Totowa, NJ: Humana Press Inc, 1997.241-262.

共引文献27

同被引文献46

引证文献6

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部